Human Antibodies Against Severe Acute Respiratory Syndrome Coronavirus-2 (Sars-Cov-2)

text
December 9, 2021

Inventors

Stefan Moese, Nike Kräutler, Cédric Cortijo, Jan Grimm, Benoit Combaluzier, Roger Nitsch, Christoph Hock

Assignees

  1. Neurimmune Ag

Abstract

Provided are novel human-derived monoclonal antibodies as well as antigen-binding fragments thereof which specifically recognize and preferably neutralize severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The anti-SARS-CoV-2 antibodies provided herein are useful in treating and diagnosis of COVID-19.

CovalX Technology Used

Epitope Mapping

Source

Contact our Scientific Team to Start the Conversation

Request A Call
Back
Categories : Patents, Epitope Mapping
text
PREVIOUS : Pharmaceutical Compositions and Pharmaceutical Products of Heterodimeric Human Interleukin-15 (hetIL-15)
NEXT : Antibodies That Bind To Pathological Tau Species And Uses Thereof
text